Trial intelligence / Profile preview

Comparison of 30% nitrous oxide with therapeutic-dose nimodipine on cerebral and systemic vascular physiology

2010-022874-15Phase 4Completed

Sponsor
University of Nottingham
Start
Oct 2010
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of nitrous oxide and nimodipine in cerebral vasospasm (2 arms), sponsored by University of Nottingham. Primary endpoint: Cerebral autoregulation. Started Oct 2010; status: completed.

02

Drugs

nitrous oxidenimodipine
03

Conditions

cerebral vasospasm

Beyond the preview

Go deeper on 2010-022874-15.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2010-022874-15.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call